ARCHIVES

Analysis Shows No Mortality Benefit From Regular PSA Screening

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

Maryland Contract Leafs New FY Awards

July 25, 1975

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985